Personalis at NeoAG Summit 2018 Boston: NOV 15-16, 2018
Presentation
Thursday, NOV 15 | 4:00 PM – 4:30 PM
Sean Michael Boyle, PhD
Director, Bioinformatics Applications
Personalis, Inc.
ImmunoID NeXT Platform: Improving Neoantigen Prediction, TME Assessment, and ctDNA Detection for Vaccine Development
- Innovative genomics methods for more comprehensive assessment of neoantigens
- Improving neoantigen to MHC binding prediction and ranking
- Assessing TME/TCR and tumor escape mechanisms that may impact vaccine response